Palaniswami Rathanaswami, PhDSenior Scientist, Biologics Discovery at Amgen, Inc.Speaker
Profile
Palaniswami Rathanaswami is working over 25 years in human therapeutic antibody generation with a special interest in antibody sequencing, engineering and screening. Developed technologies to measure the affinities in femtomolar range and measuring the affinity for on-cell membrane expressed targets. Author or inventor on more than 40 papers and patents.